{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:48:33Z","timestamp":1789015713709,"version":"build-2803163510"},"reference-count":24,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,11,7]]},"abstract":"<jats:p>Recommendations for communicating Alzheimer\u2019s disease (AD) biomarkers include pre-disclosure participant education and counseling, to allow individuals to make an informed decision. In a cohort of largely non-Hispanic White, cognitively unimpaired older adults from the Wisconsin Registry for Alzheimer\u2019s Prevention, we conducted a structured amyloid PET disclosure process that included knowledge assessment and education. Baseline participant knowledge about AD biomarkers and research was high, but information needs existed around dementia causes, early AD symptoms, genetic information, and psychosocial consequences of disclosure. Knowledge scores increased after education, highlighting the potential of brief educational interventions to improve informed decision-making about biomarker disclosure.<\/jats:p>","DOI":"10.3233\/jad-230732","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T11:43:38Z","timestamp":1696333418000},"page":"515-522","source":"Crossref","is-referenced-by-count":4,"title":["Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants\u2019 Knowledge about Alzheimer\u2019s Disease Biomarkers"],"prefix":"10.1177","volume":"96","author":[{"given":"Fred B.","family":"Ketchum","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Erickson","sequence":"additional","affiliation":[{"name":"Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin E.","family":"Basche","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Geriatrics & Gerontology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel A.","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Geriatrics & Gerontology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Rosario","sequence":"additional","affiliation":[{"name":"Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Geriatrics & Gerontology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA"},{"name":"Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay R.","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Geriatrics & Gerontology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA"},{"name":"Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-230732_ref1","doi-asserted-by":"crossref","first-page":"e12150","DOI":"10.1002\/dad2.12150","article-title":"Disclosure of preclinical Alzheimer\u2019s disease biomarker results in research and clinical settings: Why, how, and what we still need to know","volume":"13","author":"Erickson","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-230732_ref2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: Mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-230732_ref3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: Towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-230732_ref4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.trci.2018.04.002","article-title":"From information to follow-up: Ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research setting","volume":"4","author":"Vanderschaeghe","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-230732_ref6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-150985","article-title":"Development of a standardized approach to disclosing amyloid imaging research results in mild cognitive impairment","volume":"52","author":"Lingler","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230732_ref7","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/WNL.0000000000206891","article-title":"Testing for Alzheimer disease biomarkers and disclosing results across the disease continuum","volume":"100","author":"Largent","year":"2023","journal-title":"Neurology"},{"key":"10.3233\/JAD-230732_ref8","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/alz.12620","article-title":"Moving beyond disclosure: Stages of care in preclinical Alzheimer\u2019s disease biomarker testing","volume":"18","author":"Ketchum","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230732_ref9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.dadm.2017.11.007","article-title":"The Wisconsin Registry for Alzheimer\u2019s Prevention: A review of findings and current directions","volume":"10","author":"Johnson","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-230732_ref10","doi-asserted-by":"crossref","first-page":"e12413","DOI":"10.1002\/trc2.12413","article-title":"Feasibility of virtual Alzheimer\u2019s biomarker disclosure: Findings from an observational cohort","volume":"9","author":"Erickson","year":"2023","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-230732_ref11","first-page":"284","article-title":"Use and effectiveness of the teach-back method in patient education and health outcomes","volume":"36","author":"Yen","year":"2019","journal-title":"Fed Pract"},{"key":"10.3233\/JAD-230732_ref12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/alz.12630","article-title":"Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial","volume":"19","author":"Fruijtier","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230732_ref13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230732_ref14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/geront\/gnp088","article-title":"The public\u2019s perceptions about cognitive health and Alzheimer\u2019s disease among the U.S. population: A national review","volume":"49","author":"Anderson","year":"2009","journal-title":"Gerontologist"},{"key":"10.3233\/JAD-230732_ref15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/gps.1037","article-title":"Knowledge of Alzheimer\u2019s disease in four ethnic groups of older adults","volume":"19","author":"Ayalon","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-230732_ref16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12888-017-1474-0","article-title":"Barriers and facilitators in accessing dementia care by ethnic minority groups: A meta-synthesis of qualitative studies","volume":"17","author":"Kenning","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.3233\/JAD-230732_ref17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/gps.2484","article-title":"A systematic review of ethnicity and pathways to care in dementia","volume":"26","author":"Mukadam","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-230732_ref18","first-page":"47","article-title":"Health literacy in individuals at risk for Alzheimer\u2019s dementia: A systematic review","volume":"7","author":"Rostamzadeh","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-230732_ref19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-200993","article-title":"Communicating 5-year risk of Alzheimer\u2019s disease dementia: Development and evaluation of materials that incorporate multiple genetic and biomarker research results","volume":"79","author":"Mozersky","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230732_ref20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jme.2009.029264","article-title":"An investigation of patients\u2019 motivations for their participation in genetics-related research","volume":"36","author":"Hallowell","year":"2010","journal-title":"J Med Ethics"},{"key":"10.3233\/JAD-230732_ref21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/JAD-2010-101536","article-title":"Clinical research participation among aging adults enrolled in an Alzheimer\u2019s Disease Center Research Registry","volume":"23","author":"Jefferson","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230732_ref22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7326\/0003-4819-140-1-200401060-00012","article-title":"A typology of shared decision making, informed consent, and simple consent","volume":"140","author":"Whitney","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.3233\/JAD-230732_ref23","doi-asserted-by":"crossref","first-page":"129S","DOI":"10.1177\/1077558712460280","article-title":"Supporting shared decision making when clinical evidence is low","volume":"70","author":"Braddock","year":"2013","journal-title":"Med Care Res Rev"},{"key":"10.3233\/JAD-230732_ref24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: A model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.3233\/JAD-230732_ref25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1377\/hlthaff.2012.1078","article-title":"Shared decision making: Examining key elements and barriers to adoption into routine clinical practice","volume":"32","author":"L\u00e9gar\u00e9","year":"2013","journal-title":"Health Aff (Millwood)"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-230732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:42Z","timestamp":1777370922000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-230732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":24,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-230732","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}